NCT07162415

Brief Summary

The goal of this clinical trial is to learn if surgery helps with wrist ganglions in adults. The main question it aims to answer is:

  • Does surgery result in better patient-reported outcomes and satisfaction over a 6-months follow-up period? Researchers will compare surgery to conservative treatment (self-administered exercises and use of the hand as tolerated) to see if surgery provides superior outcomes. Participants will:
  • Be randomly assigned to receive either surgery or conservative treatment
  • Complete questionnaires about wrist pain, function, quality of life, satisfaction, and recovery at 3, 6, and 12 months

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
116mo left

Started Jan 2026

Longer than P75 for not_applicable

Geographic Reach
2 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jan 2026Dec 2035

First Submitted

Initial submission to the registry

September 1, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 9, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

January 13, 2026

Completed
8.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2034

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2035

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

8.9 years

First QC Date

September 1, 2025

Last Update Submit

January 19, 2026

Conditions

Keywords

ganglionwrist

Outcome Measures

Primary Outcomes (1)

  • Patient-Rated Wrist/Hand Evaluation (PRWHE) pain score

    The PRWHE is a 15-item questionnaire that is designed to measure wrist pain and disability in activities of daily living. Symptoms are described as average over the past week. The PRWHE consists of two subscales: pain and function. The PRWHE pain includes five items with combined score from 0 (no pain) to 50 (worst ever).

    6 months follow-ups

Secondary Outcomes (9)

  • PRWHE pain score

    3 and 12 months follow-ups

  • PRWHE function score

    3, 6, and 12 months follow-ups

  • PRWHE total score

    3, 6, and 12 months follow-ups

  • Global improvement

    3, 6, and 12 months follow-ups

  • Patient Accepted Symptom State (PASS)

    3, 6, and 12 months follow-ups

  • +4 more secondary outcomes

Study Arms (2)

Surgery

EXPERIMENTAL
Procedure: Open resectionProcedure: Arthroscopic resection

Conservative treatment

ACTIVE COMPARATOR
Other: Conservative treatment

Interventions

A transverse or longitudinal incision is done depending on surgeon's preference. The ganglion and its pedicle are traced up to its origin. The pedicle is resected tangentially, usually, from the SL ligament for dorsal ganglions and depending on the site for volar ganglion. Wrist capsule is not closed.

Surgery

Portals are selected by surgeon's preference. The pedicle of the ganglion is located and resected with a shaver. It is not necessary to remove all the ganglion walls. The portal incisions do not need to be sutured.

Surgery

Participant will be informed about the natural course of wrist ganglions. The conservative treatment may include needle aspiration of the ganglion, but it is not performed routinely. Participants are informed that wrist loading in extension may exacerbate the pain, and that the pain is not a sign of further injury to wrist joint. They can avoid heavy use it if they have too much pain, but they are advised to use hand as tolerated. Participants may use NSAIDs and acetaminophen for pain management as needed; however, the protocol does not specify a required course or dosage. A simple self-implemented exercise therapy instructions are given to every participant.

Conservative treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • wrist pain located in the ganglion area
  • diagnosis of ganglion of the wrist, based on clinical examination or imaging findings
  • age over 18 years
  • ability to fill out the Finnish or English version of the questionnaires

You may not qualify if:

  • pregnant or breast feeding
  • other known wrist pathology that likely explains the pain
  • previous surgical treatments of the wrist
  • wrist ganglion presumed to be related to a work injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Helsinki University Hospital

Helsinki, 00029, Finland

NOT YET RECRUITING

Hospital Nova of Central Finland

Jyväskylä, 40620, Finland

NOT YET RECRUITING

Tampere University Hospital

Tampere, 33521, Finland

RECRUITING

National University Hospital

Singapore, 119228, Singapore

NOT YET RECRUITING

MeSH Terms

Conditions

Ganglion CystsConnective Tissue DiseasesMucinoses

Interventions

MeniscectomyConservative Treatment

Condition Hierarchy (Ancestors)

CystsNeoplasmsSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Orthopedic ProceduresSurgical Procedures, OperativeTherapeutics

Central Study Contacts

Lasse Linnanmäki, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the nature of the interventions and inability to blind the participants with placebo surgery (as the visible mass would reveal the allocation after surgery), blinding is not possible. Since the outcomes are participant reported, we will not attempt to blind the investigator or other personnel.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The trial design is multicentre, randomized, parallel group (1:1) controlled, superiority trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2025

First Posted

September 9, 2025

Study Start

January 13, 2026

Primary Completion (Estimated)

December 1, 2034

Study Completion (Estimated)

December 1, 2035

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

On request and if current legislation allows, we will provide the anonymized data of the study.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
The data will be available after the trial conclusion. All data will be retained for fifteen years following the conclusion of the trial.
Access Criteria
On request.

Locations